Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
CZ
Not CommonRésumée par IA
Cinnamomum Zeylanicum Leaf
Cinnamomum zeylanicum
utilisation dentaire antimicrobienne dans la médecine Siddha
PubMed · Effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract on lipid profile, glucose levels and its safety in adults: A randomized, double-blind, controlled trial. (2025)
PubMed · Chemical composition, antioxidant and antimicrobial activity of essential oils from tangerine (<i>Citrus reticulata</i> L.), grapefruit (<i>Citrus paradisi</i> L.), lemon (<i>Citrus lemon</i> L.) and cinnamon (<i>Cinnamomum zeylanicum</i> Blume). (2021)
Révisé par : HerbAlly Editorial Team, Medical herbalists and healthcare professionals
Dernière mise à jour : April 2026
Calculer une dose sûre de Cinnamomum Zeylanicum Leaf
Calculateur gratuit de posologie — doses adultes et enfants selon le poids.
How does cinnamon leaf essential oil work for pain relief?
Cinnamon leaf essential oil works primarily through its high eugenol content (70-85%), which acts as a natural analgesic and antimicrobial agent. Eugenol inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and inflammation. It also modulates TRPV1 receptors and voltage-gated sodium channels, producing a local anesthetic effect similar to clove oil. The beta-caryophyllene component contributes additional anti-inflammatory effects through CB2 receptor activation. This mechanism makes it effective for dental pain and topical muscle relief. Evidence Level: C (preclinical studies).
Does cinnamon leaf interact with any medications?
Cinnamon leaf may interact with anticoagulant and antiplatelet medications such as warfarin, aspirin, and clopidogrel. The eugenol content has mild blood-thinning properties that could increase bleeding risk when combined with these drugs. Eugenol may also affect cytochrome P450 liver enzymes, potentially altering the metabolism of certain prescription medications. People with diabetes should monitor blood glucose closely, as cinnamon may enhance the effects of hypoglycemic medications. Consult a healthcare provider before combining with prescription drugs. Evidence Level: C (theoretical interactions).
What is the recommended dosage for cinnamon leaf tea?
For adults, the traditional dosage is 2-4 grams of dried cinnamon leaf prepared as a tea, consumed up to three times daily for digestive complaints. For topical applications, cinnamon leaf essential oil should be diluted to a maximum of 1% concentration (approximately 5-6 drops per tablespoon of carrier oil) to prevent skin irritation. Internal use of the essential oil is not recommended without professional supervision. These recommendations are based on traditional use and limited clinical evidence. Evidence Level: C.
Is cinnamon leaf safe during pregnancy?
No, cinnamon leaf is not safe during pregnancy. The high eugenol content has uterotonic properties, meaning it can stimulate uterine contractions and potentially cause miscarriage or premature labor. This risk applies to both the dried leaf and especially the concentrated essential oil. Pregnant women should avoid cinnamon leaf products entirely, particularly during the first and third trimesters. Breastfeeding women should also avoid therapeutic doses. Evidence Level: C (traditional knowledge and pharmacological data).
What are the side effects of cinnamon leaf essential oil?
The most common side effect is skin irritation, contact dermatitis, or allergic reactions, particularly when applied undiluted. Eugenol is a known skin sensitizer that can cause redness, burning, and blistering in sensitive individuals. Internal use may cause gastrointestinal upset, nausea, or liver strain with prolonged high doses. People with pre-existing liver disease should avoid cinnamon leaf essential oil entirely due to potential hepatotoxicity. Always perform a patch test before topical application and use proper dilution. Evidence Level: C (case reports and traditional use).
What is the difference between cinnamon leaf oil and cinnamon bark oil?
Cinnamon leaf oil and bark oil differ significantly in chemical composition and traditional uses. Leaf oil contains 70-85% eugenol with only trace cinnamaldehyde, making it primarily antimicrobial and analgesic. Bark oil contains 60-80% cinnamaldehyde with lower eugenol, giving it stronger antifungal properties but higher skin sensitization potential. Leaf oil is generally considered safer for topical use when properly diluted. In Sri Lankan and Siddha medicine, the leaf is preferred for dental and antimicrobial applications, while bark is used for digestive purposes. Evidence Level: C (analytical studies and traditional use).
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 29 articles PubMed · modèle : gemma4:31b
Résumé
Cinnamomum zeylanicum (Ceylon cinnamon) is a medicinal plant used for its antioxidant, antimicrobial, and blood glucose-lowering properties [PMID: 29282046, PMID: 24817901].
Contexte
Cinnamomum zeylanicum, also known as 'true cinnamon' or Ceylon cinnamon, is an indigenous tree of Sri Lanka belonging to the Lauraceae family [PMID: 21929331, PMID: 24817901]. It is used globally as a spice and aromatic crop in flavoring, perfumery, and medicines [PMID: 21929331].
Usages traditionnels
In traditional medicine, it is considered a remedy for respiratory, digestive, and gynaecological ailments [PMID: 24148965]. It has also been used in Ayurvedic, Chinese traditional, and folk medicine as a galactogogue [PMID: 40986675].
Composés actifs
The leaf oil's major component is eugenol [PMID: 21929331, PMID: 363362]. Other active compounds include (E)-cinnamaldehyde (72.98% in leaf oil), benzyl benzoate, trans-Cinnamyl acetate, polyphenols, and cinnamic acid [PMID: 36676085, PMID: 40986675].
Mécanisme d'action
Mechanisms for improving glycemic control include insulin-mimetic effects in-vitro [PMID: 41412108], inhibition of pancreatic α-amylase and α-glucosidase [PMID: 22671971], and modulation of hepatic glucose metabolism via changes in Pyruvate kinase (PK) and Phosphenol Pyruvate Carboxikinase (PEPCK) [PMID: 26475130]. It may also increase expression of lipolysis-related proteins (AMPK, p-ACC, CPT-1) and reduce lipid-synthesis proteins (SREBP-1c, FAS) [PMID: 38140369].
Preuves cliniques
Preuve AInflammation
Pooled analysis showed significant reductions in serum C-reactive protein (CRP) [PMID: 30670254]
Preuve BType 2 Diabetes Mellitus
Clinical trials have evaluated C. zeylanicum extract for effects on HbA1c and fasting plasma glucose [PMID: 41412108, PMID: 39854533]
Preuve BHyperlipidemia
Studied for its effect on serum low-density lipoprotein cholesterol (LDL-C) and other lipid parameters [PMID: 39854533]
Sécurité et effets indésirables
Ceylon cinnamon is generally recognized as safe (GRAS) by the U.S. FDA for use as a flavoring [PMID: 40986675]. It is generally well tolerated, though occasional bloating, dyspepsia, heartburn, and nausea have been reported [PMID: 40986675].
Grossesse et allaitement
No data exist on the safety of cinnamon in nursing mothers or infants [PMID: 40986675].
Synthèse des preuves
Evidence ranges from high-level meta-analyses for inflammatory markers to ongoing randomized controlled trials for glycemic and lipid control; however, some systematic reviews note a historical lack of human-specific studies for C. zeylanicum compared to C. cassia [PMID: 30670254, PMID: 22671971].
Sources PubMed
1.PMID: 39854533 (2025) — Effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract on lipid profile, glucose levels and its safety in adults: A randomized, double-blind, controlled trial. · PloS one
2.PMID: 40986675 (2006) — Chemical composition, antioxidant and antimicrobial activity of essential oils from tangerine (Citrus reticulata L.), grapefruit (Citrus paradisi L.), lemon (Citrus lemon L.) and cinnamon (Cinnamomum zeylanicum Blume). · Zeitschrift fur Naturforschung. C, Journal of biosciences
3.PMID: 41412108 (2025) — Efficacy and Safety of Cinnamomum zeylanicum (Ceylon cinnamon) for diabetes mellitus: a randomized, double blind, placebo-controlled clinical trial. · Diabetes & metabolic syndrome
4.PMID: 27771918 (2016) — Cinnamon and Chronic Diseases. · Advances in experimental medicine and biology
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
— Cinnamon (Cinnamomum zeylanicum) as an antidote or a protective agent against natural or chemical toxicities: a review.
· Drug and chemical toxicology
6.PMID: 24817901 (2014) — Cinnamon: a multifaceted medicinal plant. · Evidence-based complementary and alternative medicine : eCAM
7.PMID: 34408544 (2021) — Cinnamomum zeylanicum Blume (Ceylon cinnamon) bark extract attenuates doxorubicin induced cardiotoxicity in Wistar rats. · Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
8.PMID: 32357577 (2020) — Cinnamon (Cinnamomum zeylanicum) Oil as a Potential Alternative to Antibiotics in Poultry. · Antibiotics (Basel, Switzerland)
9.PMID: 36676085 (2023) — Comprehensive Metabolite Profiling of Cinnamon (Cinnamomum zeylanicum) Leaf Oil Using LC-HR/MS, GC/MS, and GC-FID: Determination of Antiglaucoma, Antioxidant, Anticholinergic, and Antidiabetic Profiles. · Life (Basel, Switzerland)
10.PMID: 28962661 (2017) — Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial. · Trials
11.PMID: 24148965 (2013) — Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review. · BMC complementary and alternative medicine
13.PMID: 21929331 (2011) — Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. · Critical reviews in food science and nutrition
14.PMID: 39589531 (2025) — Molecular, cellular, and metabolic insights of cinnamon (Cinnamomum zeylanicum) advantages in diabetes and related complications: condiment or medication? · Naunyn-Schmiedeberg's archives of pharmacology
15.PMID: 22518078 (2012) — Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model. · Pharmacognosy research
16.PMID: 38140369 (2023) — Effects of Cinnamon (Cinnamomum zeylanicum) Extract on Adipocyte Differentiation in 3T3-L1 Cells and Lipid Accumulation in Mice Fed a High-Fat Diet. · Nutrients
17.PMID: 28951761 (2017) — Antiamylase, Anticholinesterases, Antiglycation, and Glycation Reversing Potential of Bark and Leaf of Ceylon Cinnamon (Cinnamomum zeylanicum Blume) In Vitro. · Evidence-based complementary and alternative medicine : eCAM
18.PMID: 40319007 (2025) — Potential of Cinnamomum zeylanicum for metabolic syndrome management: insights from in vivo and human studies. · Journal of integrative medicine
19.PMID: 30144878 (2018) — To what extent does cinnamon administration improve the glycemic and lipid profiles? · Clinical nutrition ESPEN
20.PMID: 27618575 (2016) — Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review. · Journal of the Academy of Nutrition and Dietetics
21.PMID: 25838932 (2015) — Effect of Cinnamomum zeylanicumon on Spermatogenesis. · Iranian Red Crescent medical journal
22.PMID: 30670254 (2019) — Effect of cinnamon (Cinnamomum Zeylanicum) supplementation on serum C-reactive protein concentrations: A meta-analysis and systematic review. · Complementary therapies in medicine
23.PMID: 26475130 (2015) — The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. · Nutrition journal
24.PMID: 363362 (1978) — Historical overview of the cinnamon industry. · CRC critical reviews in food science and nutrition
25.PMID: 40650258 (2025) — Comprehensive Phytochemical Analysis and Evaluation of Antioxidant, Antimicrobial, Cytotoxic, and Immunomodulatory Activities of Commercial Cinnamon Bark Essential Oil (Cinnamomum zeylanicum L.). · International journal of molecular sciences
26.PMID: 29282046 (2017) — Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial. · BMC complementary and alternative medicine
27.PMID: 22671971 (2012) — Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. · Diabetic medicine : a journal of the British Diabetic Association
28.PMID: 32837101 (2022) — Immunity against COVID-19: Potential role of Ayush Kwath. · Journal of Ayurveda and integrative medicine